Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 23;15(1):48.
doi: 10.1186/s13321-023-00720-0.

In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences

Affiliations

In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences

Su-Qing Yang et al. J Cheminform. .

Abstract

Identification and validation of bioactive small-molecule targets is a significant challenge in drug discovery. In recent years, various in-silico approaches have been proposed to expedite time- and resource-consuming experiments for target detection. Herein, we developed several chemogenomic models for target prediction based on multi-scale information of chemical structures and protein sequences. By combining the information of a compound with multiple protein targets together and putting these compound-target pairs into a well-established model, the scores to indicate whether there are interactions between compounds and targets can be derived, and thus a target prediction task can be completed by sorting the outputted scores. To improve the prediction performance, we constructed several chemogenomic models using multi-scale information of chemical structures and protein sequences, and the ensemble model with the best performance was used as our final model. The model was validated by various strategies and external datasets and the promising target prediction capability of the model, i.e., the fraction of known targets identified in the top-k (1 to 10) list of the potential target candidates suggested by the model, was confirmed. Compared with multiple state-of-art target prediction methods, our model showed equivalent or better predictive ability in terms of the top-k predictions. It is expected that our method can be utilized as a powerful computational tool to narrow down the potential targets for experimental testing.

Keywords: Chemogenomic; Ensemble model; Target prediction; XGBoost.

PubMed Disclaimer

Conflict of interest statement

The authors declare neither competing financial interests nor non-financial competing interests.

Figures

Fig. 1
Fig. 1
Category distribution of 859 targets for prediction
Fig. 2
Fig. 2
The distribution of the numbers of the positive samples and negative samples associated with each target
Fig. 3
Fig. 3
ROC curves of models derived from different descriptors (integrated or separated groups) on the stratified tenfold CV
Fig. 4
Fig. 4
ROC curves of three ensemble models on the stratified tenfold CV
Fig. 5
Fig. 5
The recall rates of six individual models and our model within various top k values (k = 1–10) measured on the stratified 10-CV

Similar articles

Cited by

References

    1. Rautio J, Meanwell NA, Di L, Hageman MJ. The expanding role of prodrugs in contemporary drug design and development. Nat Rev Drug Discovery. 2018;17(8):559–587. doi: 10.1038/nrd.2018.46. - DOI - PubMed
    1. Harrison RK. Phase II and phase III failures: 2013–2015. Nat Rev Drug Discovery. 2016;15(12):817. doi: 10.1038/nrd.2016.184. - DOI - PubMed
    1. Peón A, Naulaerts S, Ballester PJ. Predicting the reliability of drug-target interaction predictions with maximum coverage of target space. Sci Rep. 2017;7(1):1–11. doi: 10.1038/s41598-017-04264-w. - DOI - PMC - PubMed
    1. Houslay MD. Melanoma, Viagra, and PDE5 inhibitors: proliferation and metastasis. Trends in cancer. 2016;2(4):163–165. doi: 10.1016/j.trecan.2016.02.007. - DOI - PubMed
    1. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003;348(14):1333–1341. doi: 10.1056/NEJMoa013128. - DOI - PubMed

LinkOut - more resources